We are live on ! Find out more
VXRT

Vaxart

Delisted

VXRT was delisted on the 7th of July, 2025.

53 hedge funds and large institutions have $25.4M invested in Vaxart in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 18 increasing their positions, 7 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

157% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 7

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

2% more funds holding

Funds holding: 5253 (+1)

1% more capital invested

Capital invested by funds: $25.2M → $25.4M (+$167K)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K

Holders
53
Holders Change
+1
Holders Change %
+1.92%
% of All Funds
1.39%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
18
Reduced
7
Closed
5
Calls
Puts
$1K
Net Calls
-$1K
Net Calls Change
-$1K
Name Holding Trade Value Shares
Change
Change in
Stake
IA
51
IFP Advisors
Florida
+$132 +6 New

VXRT Hedge Fund Activity: Q4 2015 in Review

53 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q4 2015, worth a combined $25.4M — up 0.66% from $25.2M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new VXRT positions and 5 closed out — a net gain of 1 holder — while 18 added to existing stakes and 7 trimmed.

The largest buyer was Senzar Asset Management, adding an estimated $347K. The largest seller was Gabelli & Co Investment Advisers, cutting an estimated $149K.

  • 53 institutional investors held Vaxart (VXRT) as of Q4 2015, up from 52 in Q3 2015.
  • Funds reported $25.4M of Vaxart stock for Q4 2015, up 0.66% quarter-over-quarter.
  • 6 funds opened new Vaxart positions in Q4 2015 and 5 closed out, a net change of +1 holder.
  • The largest Vaxart buyer in Q4 2015 was Senzar Asset Management, an estimated $347K added.
  • The largest Vaxart seller in Q4 2015 was Gabelli & Co Investment Advisers, an estimated $149K sold.

Based on aggregated 13F filings for Q4 2015.